Latest Content

Raising Awareness for Adolescents and Young Adults with Cancer

April 21st 2025, 8:00pm

By Carly Stafford Dixon

Video

Carly Stafford Dixon, a rare cancer survivor, highlights the need for AYA cancer awareness to improve support, visibility and access to vital resources.

Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers

April 21st 2025, 7:00pm

By Spencer Feldman

Article

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian.

My 11-Year Metastatic Breast Cancer Story Defied the Standard Path

April 21st 2025, 5:00pm

By Marissa Holzer

Article

Diagnosed in 2014, I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.

Enhertu Combo Improves PFS in HER2+ Metastatic Breast Cancer

April 21st 2025, 4:00pm

By Ryan Scott

Article

Enhertu plus Perjeta demonstrated improvement in progression-free survival versus standard treatment in HER2-positive metastatic breast cancer.

Trodelvy Plus Keytruda May Slow Progression in mTNBC

April 21st 2025, 3:00pm

By Alex Biese

Article

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

Pausing BTKi for Vaccine Did Not Boost Immunity in CLL

April 21st 2025, 1:00pm

By Spencer Feldman

Article

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be recommended, a trial found.

“Chillin’ Out” and Finding Our Cancer Community

April 20th 2025, 6:00pm

By Andrew Schorr

Article

After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the face of chronic blood cancers.

Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes

April 20th 2025, 2:00pm

By Dr. Petros Grivas

Video

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial.

Optimal Jakafi Dosing Associated With Improved Outcomes in Myelofibrosis

April 19th 2025, 6:00pm

By Alex Biese

Article

Optimal dosing of Jakafi was associated with improved efficacy and manageable safety in patients with myelofibrosis, according to the ROMEI clinical trial.

Illuminating Compassion in Cancer Care

April 19th 2025, 2:00pm

By Mike Hennessy Jr.

Article

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation.

Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma

April 18th 2025, 9:00pm

By Alex Biese

Article

There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.

Recognizing Symptoms During Head and Neck Cancer Awareness Month

April 18th 2025, 8:00pm

By Dr. Zafar Sayed

Video

Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.

AI Tool May Better Predict Transplant Risk in Myelofibrosis

April 18th 2025, 7:00pm

By Spencer Feldman

Article

An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert.

Daffodils and Determination from a Patient with Chronic Lymphocytic Leukemia

April 18th 2025, 5:00pm

By Chester Freeman

Article

Each spring, I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.

First Patient Dosed in a Phase 1/2 Trial for Small Cell Lung Cancer

April 18th 2025, 4:00pm

By Ryan Scott

Article

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus immune checkpoint inhibitors.